Medical Information Only. Always consult your healthcare provider before enrolling in any clinical trial.
NCT00575783 · ClinicalTrials.gov registry record
Impact of Hypoglycemia Unawareness on Brain Metabolism Cognition in T1DM
A clinical trial, sponsored by Yale University.
- Completed
- Registry status
- 51
- Enrollment target
NCT00575783: Completed study, sponsored by Yale University.
NCT00575783 is a clinical trial that has completed, run by Yale University. The registered enrollment target is 51 participants. According to ClinicalTrials.gov, the official US trial registry.
The verdict
NCT00575783 has completed, sponsored by Yale University.
- COMPLETED
- Registry status
- 51 participants
- Enrollment target
Study Summary
The research study is designed to examine the impact of low blood sugar on brain function in individuals with Type 1 Diabetes who have frequent and severe hypoglycemia (low blood sugar) compared to those who do not.
Trial Details
| Field | Value |
|---|---|
| Enrollment Target | 51 participants |
| Start Date | 2005-08 |
| Est. Completion | 2008-08 |
What the finished NCT00575783 record still lists
NCT00575783 is an observational study that tracks outcomes without assigning an intervention. The registry caps enrollment at 51 participants, a relatively small participant target.
The record links to 0 conditions, and to 0 interventions.
NCT00575783 does not publish any study locations in the registry export this page uses.
Frequently Asked Questions
What is clinical trial NCT00575783 about?
NCT00575783 is a clinical study titled "Impact of Hypoglycemia Unawareness on Brain Metabolism Cognition in T1DM". The research study is designed to examine the impact of low blood sugar on brain function in individuals with Type 1 Diabetes who have frequent and severe hypoglycemia (low blood sugar) compared to those who do not.
What is the current status of trial NCT00575783?
This trial is currently completed. The enrollment target is 51 participants. The study started on 2005-08. Estimated completion is 2008-08.
Who is sponsoring clinical trial NCT00575783?
This trial is sponsored by Yale University, which has 1,492 total clinical trials registered on ClinicalTrials.gov.
Learn More About Clinical Trials
Nationwide trials with similar profiles
Cross-condition peers matched on enrollment target and registry start date, not the same-condition list above.
Similar enrollment target
- NCT02701153 · 51 participants · NA
Phase II Study of 5-Day Hypofractionated Preoperative Radiation Therapy for Soft Tissue Sarcomas: Expansion Cohort
- NCT03663790 · 51 participants · NA
Effects of Gait Retraining on Lower Extremity Biomechanics
- NCT03874052 · 51 participants · Phase 1
Ruxolitinib in Combination With Venetoclax With and Without Azacitidine in Treating Patients With Relapsed or Refractory Acute Myeloid Leukemia
- NCT04704661 · 51 participants · Phase 1
Testing the Combination of Two Anti-cancer Drugs, DS-8201a and AZD6738, for The Treatment of Advanced Solid Tumors Expressing the HER2 Protein or Gene, The DASH Trial
Similar registry start date
- NCT05988463 · started 2027-01-01 · Phase 1
Dose-Escalation Study of Artesunate Patients With IPF
- NCT07219706 · started 2026-12-10 · NA
Dietary Fiber and Time Restricted Eating
- NCT02831335 · started 2026-12-01
Technical Development of Multi-Parametric Renocerebral MRI
- NCT05962346 · started 2026-12 · NA
Fetal Endoscopic Tracheal Occlusion for Congenital Diaphragmatic Hernia